#	Pagina
attuale pagina	/open-h2020/projects/206799/index.html

Opendata, web and dolomites

SkinXCare

Integral cell-biology platform for the development of the first effective treatment of radiodermatitis.

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

SkinXCare project word cloud

Explore the words cloud of the SkinXCare project. It provides you a very rough idea of what is the project "SkinXCare" about.

market skinsim enabled markets born private skinxcare first business kinome thanks cagr segments compounds care data mission dermatological opportunity molecular underlying 2025 celular rational combination solutions seek segment diseases scientific cell figures combinations dermatology platform bioinformatic biology group innohealth formulations cellular valued vitro biochemical vision unmet clinical assays synergistic solution billion complexity disease 7 severe player undergoing until something 2015 incos patients demonstrating patented sustain proteomic cancer uniqueness highest radiotherapy treatment 24 predicted ingredients grow damages company tools radiodermatitis integrates therapeutic active skin efficient simderma

Project "SkinXCare" data sheet

The following table provides information about the project.

Coordinator	INNOVATIVEHEALTH GROUP SL Organization address address: CALLE HERMOSILLA NUMERO 149 1B city: MADRID postcode: 28028 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://www.innohealthgroup.com/simhealth/skinxcare
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2016
Duration (year-month-day)	from 2016-12-01 to 2017-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	INNOVATIVEHEALTH GROUP SL INNOVATIVEHEALTH GROUP SL Organization address address: CALLE HERMOSILLA NUMERO 149 1B city: MADRID postcode: 28028 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	coordinator	50˙000.00

Map

Project objective

InnoHealth Group is a private company born with the mission of offering novel dermatological formulations, with a major focus on the rational development (scientific-based approach) of new and more effective therapeutic solutions to dermatological diseases. Our vision is to become a leading player of the therapeutic dermatology and skin care markets segments, something that will be enabled thanks to our patented cell biology platform for the development of novel products. Our platform is the only one in the market that integrates novel bioinformatic tools based on cellular proteomic/kinome data (SkinSim and INCOS) and in vitro assays (SimDerma) for the rational design and development of new dermatological formulations. The combination of these tools in the platform allows identifying the molecular/celular targets involved in skin diseases and the combinations of active ingredients/compounds with the highest synergistic activity in these targets for disease treatment. This makes our platform a key enabling technology for the development of new dermatological products, especially in treatment of skin diseases without a known efficient therapeutic solution because of the complexity in the cellular and biochemical damages underlying such diseases. In the SkinXCare project we seek demonstrating the potential of our platform by its use in the development of the first effective treatment of radiodermatitis, a severe skin condition that affects cancer patients undergoing radiotherapy and still remains an unmet clinical condition. Thanks to the uniqueness of the solution proposed in the SkinXCare project, we seek becoming a leading player of therapeutic dermatology market. This market segment was valued at €24.5 billion on 2015 and is predicted to grow at a CAGR of 6.7% until 2025, key figures that further sustain the SkinXCare business opportunity.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SKINXCARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SKINXCARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

PD_Pal (2019)

Palliative care in Parkinson’s disease

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development